Results 171 to 180 of about 944,744 (294)

Induction chemoimmunotherapy may achieve non-inferior outcomes to consolidation immunotherapy in patients with unresectable stage III NSCLC: a real-world multicenter retrospective study. [PDF]

Front Immunol
Guan S, Wang Y, Liu Q, Yan M, Ren K, Wang J, Bi N, Zhao L.   +7 more
europepmc   +1 more source

CAR T cell immunotherapy for human cancer

Science, 2018
C. June, Roddy S. O’Connor, O. Kawalekar, S. Ghassemi, M. Milone   +4 more
semanticscholar   +1 more source

Editorial: Artificial intelligence for cancer immunotherapy. [PDF]

Front Immunol
El Naqa I, Pilon-Thomas S, Deutsch E.
europepmc   +1 more source

Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG [PDF]

, 1979
E Yarkoni, Leona C. Peters, H. J. Rapp, Michael G. Hanna, J.T. Hunter   +4 more
openalex   +1 more source

Macrophages as regulators of tumour immunity and immunotherapy

Nature reviews. Immunology, 2019
D. DeNardo, B. Ruffell
semanticscholar   +1 more source

Progress in immunotherapy

Science China Life Sciences, 2023
Sun, Bing, Xia, Ningshao, Zhang, Xuan
openaire   +2 more sources

Advances in Multimodal Imaging Techniques for Evaluating and Predicting the Efficacy of Immunotherapy for NSCLC. [PDF]

Cancer Manag Res
Liu J, Xie M, Shen J, Yao J, Lin X, Bao X, Zhang X, Liang Y, Yang Y, Jiang G, Diao X, Han W, Du H, Xue X, Wu J.   +14 more
europepmc   +1 more source

BCG immunotherapy of rat sarcomata [PDF]

, 1973
R W Baldwin, M V Pimm
openalex   +1 more source

HLA-Bw4-I-80 isoform differentially influences clinical outcome as compared to HLA-Bw4-T-80 and HLA-A-Bw4 isoforms in rituximab or dinutuximab-based cancer immunotherapy [PDF]

, 2017
et al,, Kahl, Brad
core   +2 more sources

349 A novel ‘off the shelf’ TCR-NK cell therapy platform for the treatment of solid tumours: development of optimised MAGE-A4 targeting TCR-NK cells for advancement into the clinic

Journal for ImmunoTherapy of Cancer, 2023
Ines Cardoso, Sylvie Pollmann, Luise U Weigand   +2 more
doaj   +1 more source